Therapeutic Potential of Probiotics: A Ray of Hope or Nightmare?
-
Published:2019-03-27
Issue:1
Volume:6
Page:18-33
-
ISSN:2213-476X
-
Container-title:Applied Clinical Research, Clinical Trials and Regulatory Affairs
-
language:en
-
Short-container-title:ACCTRA
Author:
Arora Malika1, Kaur Navdeep2, Bansal Parveen2, Baldi Ashish3
Affiliation:
1. Multi Disciplinary Research Unit, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India 2. University Center of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, Punjab, India 3. Department of Pharmaceutical Sciences, Maharaja Ranjit Singh Punjab Technical University, Bathinda, India
Abstract
Background:The role of various probiotic microorganisms with a particular emphasis on their therapeutic use in human health and disease has been highlighted by diverse scientific research reports. Due to improvement and introduction of new technologies useful to understand the functionality and mode of action of probiotics with respect to nutritional as well as health perspectives, the research on probiotics has recently grabbed the attention of manufacturers, regulators as well as researchers. Currently there are clinical trial based evidences to support the effectiveness of probiotic interventions in various types of diarrheal diseases, chronic gastrointestinal inflammatory disorders, hypercholesterolemia, hypertension, diabetes, oral health etc. However, due to inadequate awareness about risks associated with the probiotics amongst physicians, regulatory authorities, consumers and manufacturers many attributes like quality, safety and efficacy require urgent attention. At the same time regulatory guidelines for these products face ambiguity. So, it is of utmost importance to evaluate the true status of probiotic products available in market with respect to all above mentioned parameters and to formulate harmonized regulatory guidelines for the manufacturing of probiotic products.Conclusion:The present compilation aims to highlight the progression of probiotic research related to therapeutic potentials of probiotics, clinical trials on probiotics, risks and regulatory concerns associated with probiotics and their use.
Publisher
Bentham Science Publishers Ltd.
Reference98 articles.
1. Whitman WB, Coleman DC, Wiebe WJ. Proc Natl Acad Sci, Prokaryotes: The unseen majority.,, 1998, 95,, 6578-6583, 2. Singh K, Kallali B, Kumar A. Asian Pac J Trop Biomed, Probiotics: A review.,, 2011, 1,, S287-S290, 3. Ganguly NK, Bhattacharya SK, Sesikeran B. Indian J Med Res, ICMR-DBT guidelines for evaluation of probiotics in food.,, 2011, 134,, 22-25, 4. Arora T, Singh S, Sharma RK. J Nutr, Probiotics: Interaction with gut microbiome and antiobesity potential.,, 2002, 29,, 591-596, 5. Gill HS, Rutherfurd KJ. Br J Nutr, Viability and dose-response studies on the effects of the immune enhancing lactic acid bacterium Lactobacillus rhamnosus in mice.,, 2001, 86,, 285-289,
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|